This trial is testing an experimental drug to treat Alzheimer's disease. 240 people aged 50-90 with mild Alzheimer's will take it orally once daily and be monitored.
- Alzheimer's Disease
1 Primary · 0 Secondary · Reporting Duration: From Baseline (Week 0) through Week 12
4 Treatment Groups
ABBV-552 Dose A
1 of 4
ABBV-552 Dose B
1 of 4
ABBV-552 Dose C
1 of 4
Placebo for ABBV-552
1 of 4
240 Total Participants · 4 Treatment Groups
Primary Treatment: ABBV-552 Dose A · Has Placebo Group · Phase 2
Who is running the clinical trial?
Age 50 - 90 · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What potential risks are associated with administering ABBV-552 Dose A to patients?
"As ABBV-552 Dose A is currently in Phase 2 of trials, our team at Power has assigned it a safety rating of 2. Meaning, while there are some data points supporting its security profile, none have been found that support efficacy." - Anonymous Online Contributor
Who is eligible to volunteer for this research endeavor?
"This clinical trial is enlisting individuals diagnosed with Alzheimer's Disease that are aged between 50 and 90. It hopes to recruit up to 240 volunteers for the study." - Anonymous Online Contributor
Is eligibility for this research study being extended to individuals of advanced age?
"This clinical trial has established a minimum age limit of 50 and an upper boundary of 90 for potential participants." - Anonymous Online Contributor
Is this research currently recruiting participants?
"Clinicaltrials.gov confirms that this study, which was initially published on April 2nd 2023 and most recently edited on March 6th 2023, is not presently searching for participants. However, there are 540 other clinical trials in need of patients at the moment." - Anonymous Online Contributor
How many venues are presently hosting this experimental research?
"For this clinical trial, 60 sites are operating such as Alliance for Research in Long Beach (ID# 246492), Pharmacology Research Institute (PRI) located in Los Alamitos (Wake) (ID# 248891), and Artemis Institute for Clinical Research based out of Riverside (ID# 250677). Other locations are also included." - Anonymous Online Contributor